Showing results (111-120 of 438) with videos related to
Sort By:
Pageof 44
The Pharmacogenomics Journal|February 5, 2021
Clinical significance of enterocyte-specific gene polymorphisms as candidate markers of oxaliplatin-based treatment for metastatic colorectal cancerMitsukuni Suenaga, Marta Schirripa, Shu Cao, et al.Frontiers in Oncology|July 11, 2025
Sex differences in toxicity and outcomes in patients with sarcoma treated in the perioperative setting at a comprehensive cancer centerIlaria Tortorelli, Benedetta Chiusole, Fabio Murtas, et al.Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|September 14, 2024
A pilot study of chlorambucil in pre-treated metastatic pancreatic adenocarcinoma patients bearing germline BRCA or other DNA damage repair system variantsCatia Carconi, Carlo Bosi, Mario Scartozzi, et al.Trials|August 4, 2025
Regorafenib versus local standard of care in patients with grade 2-3 meningioma no longer eligible for loco-regional treatments: a phase II randomized controlled trial (the MIRAGE study)Alberto Bosio, Giulia Cerretti, Marta Padovan, et al.Frontiers in Pharmacology|May 1, 2018
Association of STAT-3 rs1053004 and VDR rs11574077 With FOLFIRI-Related Gastrointestinal Toxicity in Metastatic Colorectal Cancer PatientsElena De Mattia, Erika Cecchin, Marcella Montico, et al.Journal of the National Cancer Institute|December 27, 2025
Impact of KRAS codon-specific mutations on survival in metastatic CRC on trifluridine-tipiracil with/without bevacizumabGiulia Maddalena, Ymke van der Pol, Oscar E Villarreal, et al.Cancers|July 8, 2020
Single Nucleotide Polymorphisms in MiRNA Binding Sites of Nucleotide Excision Repair-Related Genes Predict Clinical Benefit of Oxaliplatin in FOLFOXIRI Plus Bevacizumab: Analysis of the TRIBE TrialMitsukuni Suenaga, Marta Schirripa, Shu Cao, et al.Experimental Gerontology|October 15, 2013
Immune senescence and cancer in elderly patients: results from an exploratory studyCristina Falci, Ketty Gianesin, Giuseppe Sergi, et al.The Oncologist|May 31, 2022
Cardiotoxicity from Capecitabine Chemotherapy: Prospective Study of Incidence at Rest and During Physical ExerciseChiara Lestuzzi, Davide Stolfo, Antonino De Paoli, et al.European Journal of Cancer (Oxford, England : 1990)|October 5, 2023
Time to recurrence and its relation to survival after recurrence in patients resected for stage III colon cancerCosimo Rasola, Pierre Laurent-Puig, Thierry André, et al.Pageof 44